Education
About Us
Working with TipRanks
Follow Us
Tengjun Biotechnology Corp. (TJBH)
OTHER OTC:TJBH
Total Valuation
Tengjun Biotechnology has a market cap or net worth of $201.42M. The enterprise value is ―.
Market Cap$201.42M
Enterprise Value―
Share Statistics
Tengjun Biotechnology has 100,711,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding100,711,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tengjun Biotechnology’s return on equity (ROE) is 0.78 and return on invested capital (ROIC) is 84.05%.
Return on Equity (ROE)0.78
Return on Assets (ROA)0.19
Return on Invested Capital (ROIC)84.05%
Return on Capital Employed (ROCE)1.07
Revenue Per Employee5.56M
Profits Per Employee420.25K
Employee Count27
Asset Turnover2.56
Inventory Turnover9.71
Valuation Ratios
The current PE Ratio of Tengjun Biotechnology is ―. Tengjun Biotechnology’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value24.96
Price to FCF0.00
Price to Operating Cash Flow119.00
PEG Ratio―
Income Statement
In the last 12 months, Tengjun Biotechnology had revenue of 150.14M and earned 11.35M in profits. Earnings per share was 0.14.
Revenue150.14M
Gross Profit140.41M
Operating Income16.06M
Pretax Income15.28M
Net Income11.35M
EBITDA16.37M
Earnings Per Share (EPS)0.14
Cash Flow
In the last 12 months, operating cash flow was 21.73M and capital expenditures 95.26K, giving a free cash flow of 21.83M billion.
Operating Cash Flow21.73M
Free Cash Flow21.83M
Free Cash Flow per Share0.22
Dividends & Yields
Tengjun Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.56
52-Week Price Change0.00%
50-Day Moving Average2.00
200-Day Moving Average2.00
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Tengjun Biotechnology upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Tengjun Biotechnology as a current ratio of 1.16, with Debt / Equity ratio of 0.00%
Current Ratio1.16
Quick Ratio1.14
Debt to Market Cap0.00
Net Debt to EBITDA-0.17
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Tengjun Biotechnology has paid 3.31M in taxes.
Income Tax3.31M
Effective Tax Rate0.22
Enterprise Valuation
Tengjun Biotechnology EV to EBITDA ratio is 21.86, with an EV/FCF ratio of 266.82.
EV to Sales2.38
EV to EBITDA21.86
EV to Free Cash Flow266.82
EV to Operating Cash Flow265.64
Balance Sheet
Tengjun Biotechnology has $25.11M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$25.11M billion.
Cash & Marketable Securities$25.11M
Total Debt$0.00
Net Cash-$25.11M
Net Cash Per Share-$0.25
Tangible Book Value Per Share$0.19
Margins
Gross margin is 93.52%, with operating margin of 10.70%, and net profit margin of 7.56%.
Gross Margin93.52%
Operating Margin10.70%
Pretax Margin10.18%
Net Profit Margin7.56%
EBITDA Margin10.91%
EBIT Margin10.70%
Analyst Forecast
The average price target for Tengjun Biotechnology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―